A Randomized Phase II Study of Carboplatin and Pemetrexed with or without Selpercatinib LY3527723 in Participants with Non-Squamous RET Fusion-Positive Stage IV Non-Small Cell Lung Cancer and Progression of Disease on Prior RET Directed Therapy Lung-MAP Sub-Study NCT 05364645

Brief Summary

Type:
Lung Cancers

Study Type:
Treatment

Phase:
II

ClinicalTrials.gov Identifier:
NCT05364645

Study #:
STUDY00149401

Start Date:
Dec 13, 2022

Full Details and Eligibility at clinicaltrials.gov

By taking part in a clinical trial, you have access to potentially effective treatments not available elsewhere. Additionally, you will contribute to cancer research, which can help other cancer patients in the future. Read the full details of this specific clinical trial by clicking on the link below.

ClinicalTrials.gov ID: NCT05364645

View Complete Trial Details & Eligibility at ClinicalTrials.gov